comparemela.com

Latest Breaking News On - First wave biopharma daily - Page 1 : comparemela.com

First Wave BioPharma (NASDAQ:FWBI) Stock Rating Reaffirmed by HC Wainwright

First Wave BioPharma (NASDAQ:FWBI) Stock Rating Reaffirmed by HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

HC Wainwright Reiterates Neutral Rating for First Wave BioPharma (NASDAQ:FWBI)

HC Wainwright Reiterates Neutral Rating for First Wave BioPharma (NASDAQ:FWBI)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

HC Wainwright Reiterates Neutral Rating for First Wave BioPharma (NASDAQ:FWBI)

First Wave BioPharma (NASDAQ:FWBI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by equities research analysts at HC Wainwright in a report issued on Monday, Benzinga reports. Separately, Roth Mkm cut their price target on First Wave BioPharma from $40.00 to $36.00 and set a “buy” rating on the stock in a report […]

First Wave BioPharma, Inc (NASDAQ:FWBI) Short Interest Up 39 7% in January

First Wave BioPharma, Inc. (NASDAQ:FWBI – Get Free Report) saw a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 176,600 shares, an increase of 39.7% from the January 15th total of 126,400 shares. Approximately 28.7% of the company’s stock are sold short. Based on […]

First Wave BioPharma (NASDAQ:FWBI) Trading Down 3%

First Wave BioPharma, Inc. (NASDAQ:FWBI – Get Free Report) traded down 3% during mid-day trading on Thursday . The stock traded as low as $4.95 and last traded at $5.14. 159,133 shares changed hands during trading, a decline of 75% from the average session volume of 644,631 shares. The stock had previously closed at $5.30. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.